0001209191-23-033191.txt : 20230531 0001209191-23-033191.hdr.sgml : 20230531 20230531192618 ACCESSION NUMBER: 0001209191-23-033191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230526 FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenman William Mariner CENTRAL INDEX KEY: 0001377258 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 23982643 MAIL ADDRESS: STREET 1: C/O CERUS CORPORATION STREET 2: 2411 STANWELL DRIVE CITY: CONCORD STATE: CA ZIP: 94520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHINOOK THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 FAIRVIEW AVENUE NORTH, SUITE 900 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-485-7051 MAIL ADDRESS: STREET 1: 400 FAIRVIEW AVENUE NORTH, SUITE 900 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH, INC. DATE OF NAME CHANGE: 20111107 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-26 0 0001435049 CHINOOK THERAPEUTICS, INC. KDNY 0001377258 Greenman William Mariner C/O CHINOOK THERAPEUTICS, INC. 400 FAIRVIEW AVE. NO., 9TH FLOOR SEATTLE WA 98109 1 0 0 0 0 Common Stock 2023-05-26 4 M 0 3300 A 24798 D Common Stock 2023-05-30 4 S 0 1155 23.30 D 23643 D Restricted Stock Units 2023-05-26 4 M 0 3300 0.00 D Common Stock 3300 0 D Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-l trading plan previously adopted by the Reporting Person and represent shares by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. Each RSU represents a contingent right to receive one share of Issuer's common stock. 100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date. /s/ Kirk Schumacher, Attorney-in-Fact 2023-05-31